Pharma's new normal - innovation and collaboration: Sharad Tyagi
Shahid Akhter, editor, ETHealthworld spoke to Sharad Tyagi, Managing Director, Boehringer Ingelheim India and President OPPI, to know more about the impact of Covid-19 lockdown on the Pharma supply chain and how the industry is geared to innovate digitally in the new normal.
Advertisement
More

- Exclusive
Focusing on Volume and Revenue Growth with Expanding Margins Amid Lab Expansion: Ameera Shah
- Exclusive

- Exclusive
BioE3 will lead the way in sustainable biotechnology, precision medicine: Dr Rajesh Gokhale
- Exclusive
COMMENTS
All Comments
By commenting, you agree to the Prohibited Content Policy
PostBy commenting, you agree to the Prohibited Content Policy
PostFind this Comment Offensive?
Choose your reason below and click on the submit button. This will alert our moderators to take actions